Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test
Quantifying IgG is critical component to test population-wide vaccination effectiveness Read more
Category: Product Launch
News about product and service launches
eNUVIO is Launching the EB-Plate
The first completely reusable 3D cell culture microplate on the market Caption: The first completely reusable 3D cell culture microplate on the market. To download image, please click here. Montreal, Canada, December 8th 2020 – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use... Read more
A Better Patient Experience at SimonMed Imaging Coming with new GE MRI Tech
SCOTTSDALE, AZ – December 8, 2020 — SimonMed Imaging, one of the largest outpatient imaging providers in the US, is pleased to be the first in Arizona to bring a new, patient-friendly MRI technology to patients. SimonMed will deploy GE Healthcare’s SIGNA Architect 3T MRI scanner with new AIR http://www.ge.com/news/press-releases/a-better-patient-experience-at-simonmed-imaging-coming-with-new-ge-mri-tech Read more
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
Roche today announced that new data on its investigational T-cell engaging bispecific antibodies, mosunetuzumab, glofitamab and cevostamab, were presented at the all-virtual 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, from 5-8 December 2020, showing encouraging activity across multiple types of blood cancer. Read more
Thermo Fisher Scientific Releases New CE-Marked COVID-19, Flu A/B, RSV Combo Kit
Single test for SARS-CoV-2, influenza (flu) A/B and RSV can detect and differentiate between diseases with similar clinical symptoms Read more
WITec China moves into a new Beijing office
To keep pace with the rapid growth of the Chinese market for scientific instruments, WITec’s representative office in Beijing has moved to a larger space, now in the Air China Plaza Tower. Our new location features a dedicated equipment demonstration laboratory where visitors can experience our latest technologies in person, and see the advantages they... Read more
New data presented at ASH 2020 reinforces the benefit/risk profile of fixed-duration Polivy plus bendamustine and MabThera/Rituxan in patients with relapsed or refractory diffuse large B-cell lymphoma
Basel, 07 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced longer-term data from the pivotal phase Ib/II GO29365 study, including data from a single-arm extension cohort of 106 additional patients, which show the benefit of Polivy® (polatuzumab vedotin) plus bendamustine and MabThera®/Rituxan® (rituximab) (BR) in people with relapsed or refractory (R/R) diffuse... Read more
New follow-up phase III data reinforce the long-term benefit of Roche’s Hemlibra for people with haemophilia A
Basel, 7 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from a new analysis of pooled, three-year follow-up data of 401 people with haemophilia A from the pivotal HAVEN 1-4 studies, which reinforce the long-term efficacy and safety profile of Hemlibra® (emicizumab).[1] These data, from adults, adolescents and children with haemophilia... Read more
Roche announces new data reinforcing the long-term benefit of Venclexta/Venclyxto-based combination for people with relapsed or refractory chronic lymphocytic leukaemia
Basel, 5 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from the pivotal phase III MURANO and CLL14 studies support the efficacy of fixed-duration, chemotherapy-free Venclexta®/Venclyxto® (venetoclax)-based combinations in certain people with chronic lymphocytic leukaemia (CLL) and provide more evidence on the potential value of minimal residual disease (MRD).... Read more
Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers
December 3, 2020 at 10:00 AM EST CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has launched an Air-Dryable RT-qPCR Mix, driving innovation in the development of molecular tests with ambient temperature stability. This specialized master mix is designed... Read more